baber/WOPTO huggingface dataset:
Patent JP-3036339-B2 (JP)
IPC: H01L21/52
Filed: 1993-12-16
Granted: 2000-04-24
Abstract: PURPOSE:To make a semiconductor device thin and to make an injection balance good in a resin sealing operation by a method wherein a part in which an IC element is to be fixed, by using an insulating adhesive tape or an insulating adhesive, onto the surface of a lead-frame inner lead part is formed in the downward direction. CONSTITUTION:Parts in which an IC element 3 is to be fixed, by using an insulating adhesive tape or an insulating adhesive 4, onto the surface of lead- frame inner leads 2 are formed 7 to the downward direction. Then, the IC element 3 is fixed and bonded to an IC-element mounting part at the lead-frame inner leads 2 which have been formed 7 to the downward direction, and wire bonding pads at the IC element 3 and the lead-frame inner leads 2 are connected by wires 5. Then, a lead frame is set on a metal mold in a resin-sealing molding process, a resin is injected, and the IC element is sealed. Lastly, lead-frame outer leads 6 are bent in a press process, they are cut, and terminals for a semiconductor element are formed.
Patent JP-3360665-B2 (JP)
IPC: G06F3/12
Filed: 1999-11-11
Granted: 2002-12-24
Abstract: An electronic printing apparatus according to the present invention provides, for a print controller, a normal operating mode and a power saving mode for which less power is required. More preferably, when the print controller is set to the power saving mode, an interface circuit for accepting a printing interrupt is maintained in the normal state, and a CPU for controlling the printing sequence enters a power saving state. Then, the print controller, while in the power saving mode, can realize a constant savings in power, and can appropriately accept an interrupt, such as a print interrupt. <IMAGE>
Patent JP-2595478-B2 (JP)
IPC: A61K8/00
Filed: 1994-12-27
Granted: 1997-04-02
Abstract: The composition of the invention comprises a first dispersion of lipid vesicles capable of penetrating the deep skin layers and containing at least one first active agent capable of treating these deep layers, and a second dispersion of lipid vesicles capable of penetrating the superficial skin layers and containing at least one second active agent, different from the first active agent, capable of treating these superficial layers. This composition is used, in particular, for antiaging, antiwrinkle, depigmenting, nutrient, slimming, hydrating, antiacne, antimycotic, antidermatitis or antipsoriatic treatment.
Patent JP-3056721-B2 (JP)
IPC: F16B12/20
Filed: 1998-11-26
Granted: 2000-06-26
Abstract: The connector comprises a pot-shaped housing which is insertable in recess of the first furniture part (24). A bolt (4) with a pin (14,15) extends over the first part can be introduced into a hole in the second part, where it can be locked by rotation. A radial operating lever (16) is connected with the bolt and penetrates a hole (21) in the housing. The operating lever is radially displaceably held on the bolt and in the pushed-in position is non-rotatably coupled with it. In an outwardly drawn position it is pivotable relative to it. In the pushed-in position, the operating lever grips with an extension (18) in a radial or lateral opening or cavity (12) in the bolt.
Patent JP-H0728058-B2 (JP)
IPC: H01L43/06
Filed: 1986-04-25
Abstract: A Hall element incorporated inside a semiconductor body has a P-N junction barrier which surrounds the active zone of the Hall element in all directions. The output of the Hall element is connected through a feedback control circuit to control the thickness of the P-N junction barrier, thereby ensuring long duration, temperture stability and linearity for the Hall element.
Patent JP-2817928-B2 (JP)
IPC: F23J15/00
Filed: 1988-03-04
Granted: 1998-10-30
Abstract: A process is presented for reducing the concentration of pollutants in an effluent from the combustion of a carbonaceous fuel. The process comprises injecting a first treatment agent into the effluent at a first temperature zone and injecting a second treatment agent into the effluent at a second temperature zone, wherein the first and second treatment agents are injected under conditions effective to reduce the effluent pollution index.
Patent JP-4390855-B2 (JP)
IPC: C12N9/64
Filed: 1997-06-27
Granted: 2009-12-24
Abstract: The present invention relates to a process for increasing a yield in units of alpha-1-PI in a solution containing alpha-1-PI which is subjected to viral inactivation by solvent-detergent treatment comprising adding to the alpha-I-PI solution prior to the solvent-detergent treatment a sugar in an amount sufficient to increase the yield of alpha-1-PI following said solvent-detergent treatment.
Patent JP-3221879-B2 (JP)
IPC: A61B17/00
Filed: 1992-10-14
Granted: 2001-10-22
Abstract: A clip applicating device deploys surgical clips to ligate ducts and/or vessels during surgical procedures. While the clip is deployed the device simultaneously delivers electrosurgical energy to the affected tissue through the clip. This causes the clip and the adjacent tissue to be fused together, resulting in more secure surgical clips. The clipping device may be configured either as a bipolar or a monopolar instrument.
Patent JP-3466621-B2 (JP)
IPC: E01C23/14
Filed: 1995-09-01
Granted: 2003-11-17
Abstract: PCT No. PCT/CA95/00505 Sec. 371 Date Feb. 27, 1997 Sec. 102(e) Date Feb. 27, 1997 PCT Filed Sep. 1, 1995 PCT Pub. No. WO96/07794 PCT Pub. Date Mar. 14, 1996A process for heating an asphalt surface and an apparatus therefor. The process comprises the steps of: igniting in a burner (30) a combustible mixture comprised of a fuel (50) and oxygen (60) to produce a hot gas; and feeding the hot gas to an enclosure having a radiative face (200) disposed above the asphalt surface (280). The asphalt surface heating apparatus comprises a hot gas producing burner (30) and an enclosure (25) comprising an inlet (120) for receiving hot gas from the burner and a radiative face (200) having a plurality of apertures. The apertures in the radiative face are of a dimension such that the hot gas: (i) heats the radiative face to provide radiation heat transfer to the asphalt surface; and (ii) passes through the apertures to provide convection heat transfer to the asphalt surface.
Patent JP-3167323-B2 (JP)
IPC: G11C7/06
Filed: 1991-09-02
Granted: 2001-05-21
Abstract: PCT No. PCT/DE91/00695 Sec. 371 Date Mar. 9, 1993 Sec. 102(e) Date Mar. 9, 1993 PCT Filed Sep. 2, 1991 PCT Pub. No. WO92/05557 PCT Pub. Date Apr. 2, 1992.The dynamic semiconductor memory which has at least one block of memory (WLB), in which s block of memory has in each case a plurality of bit line blocks (TB, TB' . . . ) which has for each bit line block a local SAN driver (LTN), and possibly also a local SAP driver (LTP) for driving the read amplifiers (LV) belonging to this bit line block (TB), in order to avoid interfering voltage drops on long driver lines, and which has, to achieve an optimized drive function, multi-stage local SAN drivers (LTN) or SAP drivers (LTP) whose transistors generally have different channel widths.
Patent JP-4095673-B2 (JP)
IPC: C12N15/18
Filed: 1997-09-22
Granted: 2008-06-04
Abstract: An isolated polynucleotide encoding motoneuronotrophic factor F6.
Patent JP-4173544-B2 (JP)
IPC: C07K14/47
Filed: 1996-11-05
Granted: 2008-10-29
Abstract: The invention concerns RAC-PK protein kinase and fragments thereof, as well as activators and inhibitors of RAC-PK protein kinase for use as medicaments, particularly in the treatment of diseases concerned with abnormalities in processes modulated by insulin, such as cellular proliferation, insulin deficiency and/or excess blood sugar levels. Moreover, the invention provides RAC-PK protein kinase for use in screening potential mimics or modulators thereof. The invention further provides a screening kit comprising the RAC-PK as an active principle, and a method for screening compounds which are candidate mimics or modulators of RAC-PK activity comprising detecting specific interactions between the candidate compounds and RAC-PK.
Patent JP-3416802-B2 (JP)
IPC: A61B17/86
Filed: 1993-04-22
Granted: 2003-06-16
Abstract: A bone screw comprises a threaded shank having an axis of rotation. A head is integral with the shank, and the head includes a surface disposed generally normal to the axis. A plurality of drive receivers are disposed about the surface wholly remote from the axis. Each of the drive receivers is adapted for engagement with a cooperating driver element of a rotary driver so that the head and thereby the shank may be rotated about the axis.
Patent JP-3551381-B2 (JP)
IPC: G02F1/01
Filed: 1992-10-30
Granted: 2004-08-04
Abstract: A new liquid crystalline light modulating cell and material are characterized by liquid crystalline light modulating material of liquid crystal and polymer, the liquid crystal being a chiral nematic liquid crystal having positive dielectric anisotropy and including chiral material in an amount effective to form focal conic and twisted planar textures, the polymer being distributed in phase separated domains in the liquid crystal cell in an amount that stabilizes the focal conic and twisted planar textures in the absence of a field and permits the liquid crystal to change textures upon the application of a field. In one embodiment, the material is light scattering in a field-OFF condition and optically clear in a field-ON condition, while in another embodiment, the material is optically clear in a field-OFF condition and light scattering in a field-ON condition. In still another embodiment, the material exhibits stability at zero field in a colored, light reflecting state, a light scattering state and multiple stable reflecting state therebetween, as well as being optically clear in the presence of a field.
Patent JP-4354528-B2 (JP)
IPC: A61P15/00
Filed: 1996-02-14
Granted: 2009-10-28
Abstract: A method of treating interstitial cystitis comprising contacting the transitional epithelium lining the urinary bladder and associated structures in a mammal having interstitial cystitis with a solution containing hyaluronic acid having a average molecular weight of not less than 2x105 Daltons in a concentration effective to treat the interstitial cystitis.
Patent JP-4358908-B2 (JP)
IPC: C07D209/48
Filed: 1997-01-02
Granted: 2009-11-04
Abstract: This invention is directed to compounds of formula I: wherein the variables are as described herein. Compounds within the scope of the present invention possess useful properties, more particularly pharmaceutical properties. They are especially useful for inhibiting the production or physiological effects of TNF in the treatment of a patient suffering from a disease state associated with a physiologically detrimental excess of tumor necrosis factor (TNF). Compounds within the scope of the present invention also inhibit cyclic AMP phosphodiesterase, and are useful in treating a disease state associated with pathological conditions that are modulated by inhibiting cyclic AMP phosphodiesterase, such disease states including inflammatory and autoimmune diseases, in particular type IV cyclic AMP phosphodiesterase. Compounds within the scope of the present invention may also inhibit an MMP, and are useful in treating a disease state associated with pathological conditions that are modulated by inhibiting MMPs, such disease states involve tissue breakdown and those associated with a physiologically detrimental excess of TNF. The present invention is therefore also directed to the pharmaceutical use of the compounds, pharmaceutical compositions containing the compounds, intermediates leading thereto and methods for the preparation of the compounds and their intermediates.
Patent JP-3145409-B2 (JP)
IPC: A61P43/00
Filed: 1996-03-20
Granted: 2001-03-12
Abstract: SOD and other active oxygen inhibitors are directly applied in combination with a barrier material at local sites of tissue injury to prevent or decrease formation of adhesions and undesirable proliferation of cells. Preferred barrier materials are polymeric hydrogels providing controlled release of AOI which are directly applied to the afflicted tissue. Examples demonstrate the effects of SOD on pelvic adhesions in the rat when administered by intraperitoneal (I.P.) bolus and by localized sustained release from a topically applied hydrogel system.
Patent ES-2234437-B2 (ES)
Title: Material para ortesis de compresion con capa interior textil separadora.
Inventor: CHIANG JACKSON
IPC: B32B25/04
Filed: 2004-01-29
Granted: 2006-04-16
Abstract: Material para órtesis de compresión con capa interior textil separadora. El presente invento proporciona un material compuesto para uso en la fabricación de órtesis elásticas para ortopedia, para soportar una parte del cuerpo por compresión. Una realización del invento es un material (400) para órtesis de compresión que tiene una capa exterior elástica (410), una primera capa textil (420), una capa textil separadora (425) y una segunda capa textil (430). La capa textil separadora permite y favorece la circulación de aire lateralmente a través del material de la órtesis. La capa exterior puede tener una pluralidad de hendiduras (550) a su través para permitir y favorecer la circulación de aire transversalmente a través del material compuesto. La pluralidad de hendiduras pueden ser arqueadas, para mejorar aún más la circulación transversal del aire por el material compuesto de la órtesis.
Patent ES-2579000-B2 (ES)
Title: Método para la preparación de nanopartículas silíceas con poros que comprenden un surfactante con actividad farmacológica inherente
Inventor: GARCIA MUNOZ RAFAEL
IPC: C07F7/02
Filed: 2015-02-03
Granted: 2017-01-25
Abstract: Método para la preparación de nanopartículas silíceas con poros que comprenden un surfactante con actividad farmacológica inherente.#La presente invención se refiere a un método para la preparación de nanopartículas silíceas con poros que comprenden un surfactante, donde dicho surfactante comprende un resto éster o amida que, al hidrolizarse libera#i) un compuesto con actividad farmacéutica, o una sal del mismo, y#ii) un compuesto que comprende un resto carboxilo, un resto hidroximetilo o un resto aminometilo unido a un resto hidrocarbonado que comprende una cadena alifática de entre 7 y 23 átomos de carbono, o una sal del mismo,#donde dicho método comprende mezclar#a) dicho surfactante; y#b) al menos un compuesto de la fórmula (B1) o (B2); y#c) al menos un compuesto de la fórmula Si(OR{sup,3}){sub,4}.
Patent AU-2001259983-B2 (AU)
Title: Fractionation and processing of oilseed meal
Inventor: MAENZ DAVID D
IPC: A23L11/30
Filed: 2001-05-14
Granted: 2006-02-09
Abstract: The present invention relates to a process for the aqueous extraction, fractionation and enzymatic treatment of oilseed materials to generate valued products with no significant low value by-product or waste streams. In particular, the fractionation scheme generates a protein-fiber feed ingredient principally for use with ruminant animals and a second dephytinized high protein fraction. The dephytinized high protein fraction has value as feed ingredient for a variety of species of animals.
Patent AU-2001279556-B2 (AU)
Title: Photodynamic treatment and UV-B irradiation of a platelet suspension
Inventor: MOHR HARALD
IPC: A61L2/10
Filed: 2001-07-04
Granted: 2006-07-06
Abstract: The invention relates to a method for inactivating viruses and for killing leukocytes in platelet suspensions by a combination of photodynamic treatment and UV-B irradiation.
Patent AU-2002212216-B2 (AU)
Title: Device for treatment of mitral insufficiency
Inventor: KIMBLAD PER OLA
IPC: A61F2/90
Filed: 2001-09-08
Granted: 2006-11-30
Abstract: A device for treatment of mitral annulus dilation comprising an elongate body (8') formed by a solid wire in the shape of an open U-shaped ring adapted to engage the wall of a coronary sinus (5) most adjacent to the mitral valve annulus when inserted into the coronary sinus; the elongate body consisting of a memory metal material which will bend when reverting to its original shape.
Patent AU-2002214052-B2 (AU)
Title: Device for emptying a food storage container which can be sealed by means of a valve
Inventor: REBORDOSA ANTONIO
IPC: F04C25/02
Filed: 2001-11-14
Granted: 2004-08-19
Abstract: The invention relates to a device for emptying food storage containers.  The invention is characterised in that the device is embodied as an attachment (1) for a hand-held electrical household appliance, particularly a rod mixer and comprises a vacuum pump (17).  The invention also relates to a method for emptying a food storage container, whereby an attachment comprising a vacuum pump is disposed on a rod mixer.  The inventive attachment is advantageous in that it is provided with a small, economical and easy to handle vacuum pump for use in the household.  In contrast to prior art no completely new household appliance with corresponding additional storage requirements needs to be added.  The inventive attachment is simple and safe to use in the household.
Patent AU-2002216256-B2 (AU)
Title: Injection device with replaceable cartridge
Inventor: WOOLSTON ROBERT
IPC: A61M5/20
Filed: 2001-12-21
Granted: 2005-08-04
Abstract: An injection device having a drive mechanism to expel selectively a dose of medicament from a medicament cartridge through a needle unit is disclosed. The injection device further comprises an electronic control unit to control the drive mechanism, and a dispense button to generate a dispense button signal to the electronic control unit indicative of the dose to be expelled in which an arm button causes a first arm button signal to be sent to the electronic control unit to permit the dose to be expelled.
Patent AU-2002217014-B2 (AU)
Title: Suspension of an EPI-hNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
Inventor: BOKMAN ANNE
IPC: A61K9/00
Filed: 2001-10-26
Granted: 2006-11-02
Abstract: The present invention concerns a suspension of crystallized particles of an EPI-hNE protein, methods for preparing said suspension, a dry powder aerosol derived from said suspension, an inhalable pharmaceutical formulation comprising said suspension or said dry powder aerosol, and the use of said inhalable pharmaceutical formulation in the treatment of various pathological conditions.
Patent AU-2002234013-B2 (AU)
Title: Traffic barrier apparatus with gate
Inventor: DYKE GERRIT ANDREW
IPC: E01F15/12
Filed: 2001-12-12
Granted: 2007-04-26
Abstract: A traffic barrier is pivotally attached to a gate by a hinge. A cover is releasably connected to the barrier and the gate and covers the hinge. When the cover is releasably connected to the barrier and the gate it will cooperate with the barrier and gate to resist relative movement between the barrier and gate at the hinge location.
Patent AU-2002321453-B2 (AU)
Title: Suspending equipment
Inventor: BOALER DEREK
IPC: F16G11/04
Filed: 2002-08-13
Granted: 2006-12-14
Abstract: Means for suspending equipment (21) from an overhead structural member (16) comprises a suspension strand (10), e.g. a length of wire rope, with a nipple (11) at one end, a toggle plate (12) with an aperture (13) through which the strand can pass but not the nipple, together with a locking device (18) having twin bores (17A, 17B) associated with wedging means (19A, 19B), the toggle plate (12) and nipple (11) being pushed through a hole (15 or 34) in the overhead structural member (16) or the equipment (21), for the toggle plate to overlie or underlie the hole, while the free end (14) of the strand (10) is passed through one bore (17A) of the locking device (18), through an eye (20) on the equipment (21) or round the equipment or through an eye (35) on the overhead structural member (16) or round the overhead structural member, and finally through the other bore (17B) of the locking device (18).
Patent AU-2002342826-B2 (AU)
Title: Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
Inventor: NGUYEN-XUAN THAO
IPC: A61P29/00
Filed: 2002-10-15
Granted: 2006-09-07
Abstract: The present invention refers to ready-to-use highly stable paracetamol injectable solutions, prepared by mixing paracetamol, water, propylene glycol, and a citrate buffer. (pH 4.5 to 6.5), and by heating said solution under preset conditions. The resulting solution may be stored for an extended period of time within a wide range of temperatures, with no paracetamol precipitation and/or its chemical modification.
Patent AU-2003201909-B2 (AU)
Title: Medical multi-chamber container
Inventor: HAMAZAKI SHIN
IPC: A61J1/00
Filed: 2003-01-08
Granted: 2008-01-10
Abstract: A medical multi-chamber container (1) comprising a container body (3) having first and second chambers (10, 11) for storing medicaments, a weak partition seal (20) for portioning the charmers (10, 11) from each other, and an outlet (32) fitted into the container body (3) for allowing the medicaments to be delivered from the second chamber (11), the container body (3) further comprising a weak discharge seal (21) partitioning the second chamber (11) from the outlet (32) and unsealably formed so as to allow the chambers (10, 11) to communicate with each other when used, characterized in that the unsealing strength of the weak discharge seal (21) is less than that of the weak partition seal (20). <IMAGE>
Patent AU-2003241765-B2 (AU)
Title: DLC film coated plastic container, and device and method for manufacturing the plastic container
Inventor: ANDO HIDEYASU
IPC: C23C16/26
Filed: 2003-05-26
Granted: 2009-08-06
Abstract: The present invention provides a plastic container having a inner wall surface coated with DLC film which has same level of oxygen barrier property as prior art and can prevent a coloring of the DLC film formed on a neck portion of the container.  The apparatus for manufacturing the DLC film coated plastic container, comprising: 
a container side electrode which forms one portion of a pressure-reducing chamber which houses a container formed from plastic, a facing electrode which faces said container side electrode and is arranged inside said container or above said opening, wherein said container side electrode and said facing electrode are made to face each other via an insulating body which forms a portion of said pressure-reducing chamber, source gas supply means which includes a supply gas inlet pipe, exhaust means, and high frequency supply means; wherein said container side electrode is formed so that the average inner hole diameter of the inner wall surrounding said neck portion when the container is housed becomes smaller than the average inner hole diameter of the inner wall surrounding said body portion, and the average distance between the outer wall of said container and the inner wall of said container side electrode in a horizontal cross section with respect to the vertical direction of said container at said neck portion becomes longer than the average distance between the outer wall of said container and the inner wall of said container side electrode in a horizontal cross section with respect to the vertical direction of said container at said body portion.
Patent AU-2003277373-B2 (AU)
Title: Site specific incorporation of keto amino acids into proteins
Inventor: SCHULTZ PETER G
IPC: C12N15/67
Filed: 2003-10-15
Granted: 2009-05-07
Abstract: Compositions and methods of producing components of protein biosynthetic machinery that include orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases, and orthogonal pairs of tRNAs/synthetases, which incorporate keto amino acids into proteins are provided. Methods for identifying these orthogonal pairs are also provided along with methods of producing proteins with keto amino acids using these orthogonal pairs.